Abstract
Different causes of mortality have been described over different decades followed by description of pathogens identified from infective episodes that led to death. A retrospective review was performed in 3,831 hospitalized systemic lupus erythematosus (SLE) patients in Peking Union Medical College Hospital from January 1986 to April 2012. The primary causes of death were identified, and the constituent ratio of specific death causes during different periods was compared. Among 3,831 hospitalized SLE patients, 268 patients died, accounting for 7.0 %. No significant difference of death rate was found between men and women, P = 0.404. The three most frequent death causes according to decade were as follows: for 1986–1995, renal involvement, lupus encephalopathy, and infections; for 1996–2005, infections, lupus encephalopathy, and renal involvement; and for 2006–2012, infections, lupus encephalopathy, and pulmonary hypertension. Certain types of deaths, primarily related to lupus activity, have decreased over time, whereas infections, often attributed to the use of corticosteroid and immunosuppressant medications, have increased gradually and changed to the most frequent death causes of SLE. Early mortality (<3 years) occurred more commonly in lupus encephalopathy, while late death (>3 years) happened more frequently in renal involvement, pulmonary artery hypertension, cardiovascular events, and cancer. In SLE death cases mainly dying from infection, mixed infections were more frequent than single pathogen infection (60.5 vs. 39.5 %), including common bacteria, fungal infection, and cytomegalovirus. Aspergillus fumigatus and Pneumocystis carinii were the two most commonly infected pathogens, and Cytomegalovirus was a frequent pathogen of mixed infection. Aggressive therapy has effectively reduced the mortality related to disease activity but also was associated with life-threatening infections. Mixed and fungal infection should be considered when SLE patients have severe infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mok CC, Kwok CL, Ho LY et al (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum 63(5):1182–1189
Bernatsky S, Boivin JF, Joseph L et al (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54(8):2550–2557
Wadee S, Tikly M, Hopley M (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) 46(9):1487–1491
Doria A, Iaccarino L, Ghirardello A et al (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119(8):700–706
Yap DY, Tang CS, Ma MK et al (2012) Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant 27(8):3248–3254
Teh C, Ling G (2013) Causes and predictors of mortality in hospitalized lupus patient in Sarawak General Hospital, Malaysia. Lupus 22(1):106–111
Kang KY, Kwok SK, Ju JH et al (2011) The causes of death in Korean patients with systemic lupus erythematosus over 11 years. Lupus 20(9):989–997
Souza DC, Santo AH, Sato EI (2012) Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis. J Rheumatol 39(3):496–503
Iriya SM, Capelozzi VL, Calich I et al (2001) Causes of death in patients with systemic lupus erythematosus in Sao Paulo, Brazil: a study of 113 autopsies. Arch Intern Med 161:1557
Bruce IN, Urowitz MB, Gladman DD et al (2003) Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study. Arthritis Rheum 48(11):3159–3167
Magder LS, Petri M (2012) Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol 176(8):708–719
Gustafsson JT, Simard JF, Gunnarsson I et al (2012) Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther 14(2):R46
Doria A, Shoenfeld Y, Wu R et al (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62:1071–1077
Moss KE, Ioannou Y, Sultan SM et al (2002) Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 61:409–413
Abu-Shakra M, Urowitz MB, Gladman DD et al (1995) Mortality studies in systemic lupus erythematosus. Results from a single center.I. Causes of death. J Rheumatol 22:1259–1264
Marcos M, Fernandez C, Soriano A et al (2011) Epidemiology and clinical outcomes of bloodstream infections among lupus patients. Lupus 20(9):965–971
Weng CT, Lee NY, Liu MF et al (2010) A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan. Lupus 19(10):1204–1209
Chen HS, Tsai WP, Leu HS et al (2007) Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology (Oxford) 46(3):539–544
Kim HJ, Park YJ, Kim WU et al (2009) Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea. Lupus 18(7):661–666
Disclosures
None.
Funding
This work was supported by the National Key Technology Research and Development Program in the 11th 5 year Plan of China (nos. 2008BAI59B02 and 2008BAI59B03) and the National Natural Science Foundation of China (no. 81202360).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fei, Y., Shi, X., Gan, F. et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol 33, 57–63 (2014). https://doi.org/10.1007/s10067-013-2383-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2383-3